AMED:NSD-Amedisys Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 119.48

Change

-3.76 (-3.05)%

Market Cap

USD 3.93B

Volume

0.23M

Avg Analyst Target

USD 161.56 (+35.22%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


AMED Stock Forecast & Price:
Based on the Amedisys Inc stock forecasts from 16 analysts, the average analyst target price for Amedisys Inc is USD 161.56 over the next 12 months. Amedisys Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Amedisys Inc is Slightly Bullish , which is based on 9 positive signals and 6 negative signals. At the last closing, Amedisys Inc’s stock price was USD 119.48. Amedisys Inc’s stock price has changed by -1.31% over the past week, -0.43% over the past month and -40.30% over the last year.

About Amedisys Inc (AMED:NSD)

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-09 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ACHC Acadia Healthcare Company Inc

-1.50 (-1.85%)

USD7.23B 26.01 16.08
LHCG LHC Group

+0.79 (+0.49%)

USD5.02B 50.09 29.81
ENSG The Ensign Group Inc

-0.58 (-0.68%)

USD4.75B 23.92 17.50
SGRY Surgery Partners Inc

-0.68 (-1.84%)

USD3.32B 63.00 14.09
AMEH Apollo Medical Holdings Inc

-2.36 (-4.46%)

USD2.39B 33.09 79.94
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
TVTY Tivity Health Inc

N/A

USD1.62B 19.06 12.00
ADUS Addus HomeCare Corporation

-0.01 (-0.01%)

USD1.50B 33.71 20.11
HCSG Healthcare Services Group Inc

-0.13 (-0.92%)

USD1.03B 35.79 17.48
CCRN Cross Country Healthcare Inc

-0.73 (-3.17%)

USD0.88B 3.86 4.03

ETFs Containing AMED

Symbol Name Weight Mer Price(Change) Market Cap
RWM ProShares Short Russell20.. 0.00 % 0.95 %

+0.32 (+1.40%)

USD0.48B
SRTY ProShares UltraPro Short .. 0.00 % 0.95 %

+1.99 (+4.16%)

USD0.21B
TWM ProShares UltraShort Russ.. 0.00 % 0.95 %

+0.42 (+2.84%)

USD0.18B
TZA Direxion Daily Small Cap .. 0.00 % 1.00 %

+1.29 (+4.17%)

USD0.45B
OLD The Long-Term Care ETF 0.00 % 0.30 %

N/A

USD0.03B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -26.19% 45% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -26.19% 45% F 40% F
Trailing 12 Months  
Capital Gain -38.35% 58% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -38.35% 58% F 38% F
Trailing 5 Years  
Capital Gain 147.73% 50% F 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 147.73% 50% F 84% B
Average Annual (5 Year Horizon)  
Capital Gain 38.74% 75% C 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.74% 75% C 87% B+
Risk Return Profile  
Volatility (Standard Deviation) 57.55% 50% F 24% F
Risk Adjusted Return 67.32% 75% C 92% A-
Market Capitalization 3.93B 86% B 86% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 28.44 65% D 31% F
Price/Book Ratio 4.12 32% F 23% F
Price / Cash Flow Ratio 20.81 23% F 15% F
EV/EBITDA 16.53 50% F 18% F
Management Effectiveness  
Return on Equity 14.62% 82% B- 78% C+
Return on Invested Capital 15.15% 83% B 84% B
Return on Assets 7.17% 91% A- 87% B+
Debt to Equity Ratio 46.39% 42% F 41% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 3.02 82% B- 49% F
Short Percent 6.27% 55% F 28% F
Beta 0.94 50% F 59% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector